Drug Discovery and Development

Let’s say there’s a Black female patient with an aggressive form of breast cancer. She meets with her oncologist to discuss a promising targeted therapy that recently won FDA approval. The drug showed strong efficacy in clinical trials, with a 65% response rate. Yet when she asks about efficacy data specific to Black women, she…

Spatial biology is revolutionizing our understanding of how cells interact with their natural environments. Although that may sound like an overstatement, it isn’t.  Spatial biology involves the use of advanced imaging and molecular techniques to visualize and map the location of cells, transcripts, proteins and their interactions within tissues. Traditional biological studies have long focused…

In 2024, the World Health Organization added 24 pathogens to its pandemic watchlist, including three that are zoonotic, meaning they spread from animals to humans. The newly added zoonotic diseases include avian influenza, mpox (previously known as monkeypox) and Sin Nombre virus, the latter of which jumps from mice to people and has a 30% fatality rate in…

COTA Healthcare recently unveiled what it calls a major breakthrough in real-world oncology data (RWD). At the heart of this achievement is a generative AI (GenAI) platform that the company says makes large-scale curation of cancer data both accurate and profitable, marking a significant shift from previous industry attempts to automate the labor-intensive RWD abstraction…